65,437 trials
Kidney Failure, Chronic · Catheter-Related Infections
Primary: Presence of a CAC-Adjudicated Catheter-Related Bloodstream Infection (CRBSI) in Subjects Receiving Hemodialysis for the Treatment of End Stage Renal Disease (ESRD)…
Obesity
Primary: Clinically Significant Weight Loss — 39; 40 Participants — p=>0.05
Antibiotic Resistant Infection · Infection
Primary: Percentage of Appropriate Antimicrobial Prescriptions Recommended — 90 percentage of prescriptions appropriate
Pigmented Villonodular Synovitis · Tenosynovial Giant Cell Tumor
Primary: The Incidence of Grade 3 and Grade 4 Adverse Events (AEs) and Defined as Dose-limiting Toxicities (DLTs) in Phase 1 — 0; 0; 0 Participants
Nicotine Addiction
Primary: DEQ - Pleasurable — 2.14; 2.05; 1.98; 2.37 score on a scale
Gout
Primary: CT Bone Erosion Score — 6.6; 7.0 Score on a scale
Natriuretic Peptides · Obesity · Nocturnal Blood Pressure
Primary: Plasma MRproANP — 17.92; 15.51 pmol/l — p=0.003
Brachial Plexus Blockade
Primary: Overall Duration of Sensory Block. — 165; 188 minutes — p=<0.001
Amyotrophic Lateral Sclerosis
Primary: Supine Slow Vital Capacity (SVC) — -6.731; -6.988 percentage — p=0.8253
Anesthesia
Primary: 1st Attempt Success With Supraglottic Airway Devices (SGAD) — 25; 21; 1; 3 Participants
Lid Wiper Epitheliopathy
Primary: Lid Wiper Epitheliopathy — 0.63; 0.25 score on a scale
Diabetes Mellitus, Type 1 · Nephropathy · Diabetic Nephropathies
Primary: Copeptin Levels — 8.3 pmol/L
Pharmacokinetic
Primary: Cmax — 508.6; 384.5; 289.5; 499.5 nmol/L
Hereditary Disease · Genetic Predisposition to Disease
Primary: Downstream Health Care Costs Attributable to BabySeq Project Disclosure: Days of Inpatient Care — 0.1; 0.0; 3.1; 3.8 Days
Healthy · Anemia
Primary: Coefficient of Variation of Rad-67 — 4.50 Coefficient of Variation percentage